U.S. Renewable Energy Stock News

MiMedx Group recently published new peer-reviewed data in the Journal of Inflammation showing that its Purion-processed DHACM and LHACM placental allografts exert multifactorial immunomodulatory effects on key inflammatory cells involved in wound healing. The findings that these allografts both temper inflammatory monocyte and macrophage activity and enhance pro-reparative functions such as efferocytosis and cell survival could strengthen the medical community’s confidence in MiMedx’s...

PAR Technology (PAR) is back in the spotlight after Wasatch Global Investors exited its position, citing weaker than expected organic growth, just as the company leans on new products like Smart Passes to reset its story. See our latest analysis for PAR Technology. That backdrop helps explain why, even with a recent 1 month share price return of about 8 percent and a 1 day gain of nearly 3 percent to 36.83 dollars, PAR’s year to date share price return is still deep in the red. Its 1 year...

Anywhere Real Estate (HOUS) is back on investors radar after a series of upbeat calls from Keefe, Bruyette & Woods, Barclays, and JP Morgan, signaling improving confidence in its residential brokerage and franchise operations. See our latest analysis for Anywhere Real Estate. Those upbeat calls land at a time when momentum is clearly building, with Anywhere Real Estate’s share price up sharply over the past quarter and its year to date share price return far outpacing its already impressive 1...

GoDaddy (GDDY) has quietly slipped this year, with the stock down around 36% year to date despite solid revenue and earnings growth, and that disconnect is exactly what has investors rechecking their assumptions. See our latest analysis for GoDaddy. Despite the drop, the 1 day and 7 day share price returns have turned positive, and that small change in tone sits against a still healthy three year total shareholder return of nearly 70%. This suggests long term holders have been well rewarded...

If you have been wondering whether KBR is a beaten down opportunity or a value trap, you are not alone. This article is going to walk through the numbers with you. After sliding to around $42.80, the stock is down 1.6% over the last week and up 5.7% over 30 days, but still sitting on a heavy year-to-date loss of 26.1% and a 23.9% drop over the past year, despite being up 51.8% over five years. That kind of whiplash performance has come alongside a steady stream of contract wins and strategic...

In recent coverage, Mizuho and Citi both initiated positive ratings on Spyre Therapeutics, highlighting its half-life extended monoclonal antibody pipeline for inflammatory bowel and other autoimmune diseases. Analysts emphasized Spyre’s ability to explore novel antibody combinations and its rheumatic disease program, with several firms now expressing broad confidence in the company’s development approach. We’ll now explore how this wave of optimistic analyst coverage, particularly around...

Expand Energy (EXE) just released a standout earnings update, with adjusted EPS jumping sharply year over year on stronger oil, gas, and NGL sales, plus sizable contributions from marketing and derivatives. See our latest analysis for Expand Energy. Even after this blowout quarter, the stock has cooled off recently, with a 30 day share price return of minus 8.1 percent. However, a 1 year total shareholder return of 17.2 percent still signals that momentum is building over the longer run. If...

HeartFlow (HTFL) has climbed about 9% in a day and 8% over the past week, an eye catching move for a relatively young medtech stock. Investors are asking whether this momentum is sustainable. See our latest analysis for HeartFlow. The latest surge comes after a choppy few months, with a 30 day share price return of 5.21% but a 90 day share price return still in negative territory, suggesting momentum is only just starting to rebuild. If HeartFlow's recent move has your attention, it could be...

Trevi Therapeutics (TRVI) just named veteran finance executive David Hastings as its next Chief Financial Officer, effective January 6, 2026, a move that immediately sharpened investor focus on the stock’s trajectory. See our latest analysis for Trevi Therapeutics. The timing of Hastings’ appointment coincides with Trevi’s 90-day share price return of nearly 50 percent and roughly 180 percent year-to-date share price gain, which together indicate firmly building momentum, supported by a...

Chimera Investment Corporation’s board declared a fourth-quarter cash dividend of US$0.37 per common share, payable on January 30, 2026, to shareholders of record as of the December 31, 2025 ex-dividend date. This dividend decision sheds light on Chimera’s ongoing approach to distributing income from its diversified mortgage asset portfolio, a key focus for income-oriented investors. We’ll now explore how this latest dividend declaration shapes Chimera Investment’s broader investment...

Earlier this week, Sphere Entertainment announced that veteran entertainment technologist Felicia Yue has joined as Executive Vice President and Chief Technology Officer, where she will oversee the advanced display, playback, interactive, and audio systems underpinning the company’s immersive Sphere venues and Sphere Studios. Her track record building widely used broadcast technologies like the NFL’s yellow 1st‑down line and CNN’s election “Magic Wall” underscores Sphere’s push to deepen its...

ANI Pharmaceuticals (ANIP) has quietly kept its momentum, with shares edging higher over the past week and delivering strong gains this year. That strength invites a closer look at what is driving the move. See our latest analysis for ANI Pharmaceuticals. With the share price now at $82.83, the recent 7 day share price return of just over 3 percent sits against a much stronger year to date share price return and a standout multi year total shareholder return record. This suggests positive...

As the U.S. stock market experiences a resurgence, with major indices like the Nasdaq and S&P 500 seeing notable gains driven by tech shares, investors are keenly observing opportunities that may arise from these fluctuations. In such an environment, identifying undervalued stocks can be crucial for those looking to capitalize on potential growth while maintaining a balanced portfolio amidst shifting market dynamics.

As the U.S. stock market experiences a surge, particularly in tech shares, investors are closely monitoring growth companies with high insider ownership as potential opportunities amidst this renewed risk appetite. In such an environment, stocks that combine robust earnings growth with significant insider stakes can offer insights into management confidence and alignment with shareholder interests.

Major stock indexes in the United States have recently experienced a surge, driven by gains in technology shares and positive economic indicators. While the term "penny stocks" might seem outdated, it still refers to shares of smaller or newer companies that can offer significant potential for growth. By focusing on those with solid financial foundations, investors can uncover opportunities that may provide stability and upside potential.

As the U.S. market navigates a landscape marked by surging tech shares and volatile index movements, investors are keenly observing how these dynamics impact small-cap stocks, particularly within the S&P 600. With major indices like the Nasdaq and S&P 500 experiencing gains driven by AI-related optimism, identifying lesser-known stocks with strong fundamentals can be key to capitalizing on potential growth opportunities amidst broader market shifts.

As the U.S. stock market experiences a resurgence, with major indexes like the Nasdaq and S&P 500 seeing notable gains driven by tech shares, investors are keenly observing opportunities across various sectors. In this dynamic environment, dividend stocks stand out as a compelling option for those seeking consistent income streams alongside potential capital appreciation.

Earlier this week, Healthcare Realty Trust Incorporated filed a Follow-on Equity Offering for up to US$1.00 billion of Class A common stock through an at-the-market program to help fund healthcare facility projects and reinforce its financial position. This capital-raising move coincides with an upgrade to a Zacks Rank #2 (Buy), reflecting improving earnings estimates and growing institutional interest in the REIT’s outpatient-focused portfolio. Next, we’ll examine how this US$1.00 billion...

In recent months, Federal Realty Investment Trust has advanced its capital recycling program by selling two assets for about US$170,000,000 and redirecting proceeds into acquisitions such as Village Pointe in Omaha and Annapolis Town Center in Maryland, while also reporting stronger-than-expected Q3 2025 FFO and revenue alongside higher full-year guidance and a new board appointment. These moves highlight how Federal Realty is using asset sales to help self-fund growth in larger retail...

Earlier this week, SLR Credit Solutions closed a US$100 million senior secured term loan for The Children’s Place, alongside a US$350 million revolving credit facility from Wells Fargo, bolstering the retailer’s liquidity after using proceeds to repay existing borrowings and fund future initiatives. This financing arrives just after The Children’s Place reported its third consecutive quarterly loss and a 13% year-on-year sales decline, underlining the tension between its funding needs and...

Earlier in December 2025, DTE Energy’s board amended its bylaws to formalize how shareholders can bring business and board nominations to annual meetings, while also explicitly permitting remote-only shareholder meetings and making minor editorial updates. Around the same time, DTE’s expanding data center commitments and related regulatory scrutiny sparked broader questions about how the company balances growth opportunities with stakeholder and policy concerns. We’ll now examine how DTE’s...

Earlier this month, Scorpio Tankers said it agreed to sell two 2016-built LR2 product tankers, STI Goal and STI Gallantry, for about US$52.3 million each by early 2026, while ordering two scrubber-fitted LR2 newbuildings at roughly US$70.8 million apiece for delivery in the third quarter of 2027. The transactions not only refresh the fleet ahead of costly 10-year surveys but also reshape capital commitments by replacing leased, aging vessels with higher-priced, future-efficient ships. Next,...

SkyWest, Inc. has recently extended its United Express footprint by launching service from Natchez-Adams County Airport to Houston, adding a third Mississippi destination and deepening its role in connecting smaller communities to major hubs. This route expansion, alongside a track record of earnings and revenue beats over the last four quarters, underscores how SkyWest is pairing operational execution with targeted growth in underserved regional markets. Next, we’ll explore how SkyWest’s...

Valuation snapshot and what the market is pricing in Before we dive into detailed models and ratios, it helps to zoom out and understand how the market is currently treating General Electric and why. GE has gone through a multi year transformation that has fundamentally reshaped the business mix, its balance sheet and how investors think about its future cash flows. That matters because a lot of the recent share price performance is not just about cyclical optimism but also about investors...